摘要
目的:研究经鼻导管高流量氧疗运用于肺癌患者术后呼吸衰竭中的价值。方法:选择2018年1-12月本院收治的74例肺癌术后呼吸衰竭患者为研究对象,根据随机数字表法分为研究组和对照组,每组37例。研究组采取经鼻导管高流量氧疗,对照组采取常规治疗,比较两组治疗前后相关指标水平变化、SF-36评分变化情况。结果:治疗前,两组呼吸、心率、PaO2、PaCO2及PaO2/FiO2水平比较,差异均无统计学意义(P>0.05);治疗1 h、6 h、1 d后及结束时,研究组各项指标均优于对照组,差异均有统计学意义(P<0.05)。治疗前,两组生理机能、生理职能、躯体疼痛、健康状况、精力、社会功能、情感职能及精神健康评分比较,差异均无统计学意义(P>0.05);治疗后,研究组上述各项评分均高于对照组,差异均有统计学意义(P<0.05)。结论:经鼻导管高流量氧疗运用于肺癌患者术后呼吸衰竭中效果显著,能够明显改善通气及循环氧合情况,提高健康质量,为预后提供保障。
Objective:To investigate the value of transnasal catheter high flow oxygen therapy in postoperative respiratory failure in patients with lung cancer.Method:A total of 74 patients with respiratory failure after lung cancer surgery admitted to our hospital from January to December 2018 were selected as the study objects.According to the random number table method,they were divided into study group and control group,37 cases in each group.The study group received high flow oxygen through the nasal catheter,the control group received conventional treatment.The changes of relevant indicators and SF-36 score before and after treatment were compared between the two groups.Result:There were no significant differences in respiration,heart rate,PaO2,PaCO2 and PaO2/FiO2 levels between the two groups before treatment (P>0.05).At 1 h,6 h,1 d after treatment,and at the end of treatment,all indexes in the study group were better than those in the control group,with statistically significant differences (P<0.05).There were no significant differences in the physical function,physical function,physical pain,health status,energy,social function,emotional function and mental health scores of the two groups before treatment (P>0.05),all the scores in the study group were higher than those in the control group after treatment,and the differences were statistically significant (P<0.05).Conclusion:Transnasal catheter high flow oxygen therapy has a significant effect on postoperative respiratory failure in patients with lung cancer,which can significantly improve ventilation and circulatory oxygenation,improve health quality,and provide guarantee for prognosis.
作者
蔡艳玲
CAI Yanling(Jiamusi Tuberculosis Prevention Hospital,Jiamusi 154007,China)
出处
《中国医学创新》
CAS
2020年第3期17-21,共5页
Medical Innovation of China
关键词
呼吸衰竭
肺癌
高流量氧疗
鼻导管
Respiratory failure
Lung cancer
High flow oxygen therapy
Nasal cannula
